Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer

World Journal of Gastroenterology

Volumn 19, Issue 22, 2013, Pages 3473-3480

  Niu, Li Zhi ^a,b   Li, Jia Liang ^a,b   Zeng, Jian Ying ^a   Mu, Feng ^c   Liao, Meng Tian ^c   Yao, Fei ^a   Li, Li ^c   Liu, Chun Yan ^c   Chen, Ji Bing ^a,c   Zuo, Jian Sheng ^a,b,c   Xu, Ke Cheng ^a,b,c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b Fuda Institute of Cryosurgery for Cancer   (China)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Cryoablation; Dendritic cell cytokine induced killer cell; Immunotherapy; Metastatic hepatocellular cancer; Survival time

Indexed keywords

ANTIBIOTIC AGENT; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CRYOABLATION; CYTOKINE INDUCED KILLER CELL; DENDRITIC CELL; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PLEURA EFFUSION; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 84879038059     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i22.3473     Document Type: Article

References (40)

1. Said A, Wells J. Management of hepatocellular carcinoma. Minerva Med 2009; 100: 51-68
2. Turner PM, Turner TJ. Validation of the crisis triage rating scale for psychiatric emergencies. Can J Psychiatry 1991; 36: 651-654 [DOI: 10.1136/gut.51.4.459]
3. Hodgson HJ. Primary hepatocellular carcinoma. Br J Hosp Med 1983; 29: 240, 246, 250 passim
4. Dusheiko GM, Hobbs KE, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet 1992; 340: 285-288 [DOI: 10.1016/0140-6736(92)92367-O]
5. Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol 2004; 5: 409-418 [DOI: 10.1016/S1470-2045(04)01508-6]
6. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390 [DOI: 10.1056/NEJMoa0708857]
7. Davis CR. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010; 17: 87-99
8. Fuss M, Salter BJ, Herman TS, Thomas CR. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology 2004; 127: S206-S217 [DOI: 10.1053/j.gastro.2004.09.035]
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [DOI: 10.1002/hep.20933]
10. Chen JB, Li JL, He LH, Liu WQ, Yao F, Zeng JY, Zhang Y, Xu KQ, Niu LZ, Zuo JS, Xu KC. Radical treatment of stage IV pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation. World J Gastroenterol 2012; 18: 7056-7062 [DOI: 10.3748/wjg.v18.i47.7056]
11. Orlacchio A, Bazzocchi G, Pastorelli D, Bolacchi F, Angelico M, Almerighi C, Masala S, Simonetti G. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol 2008; 31: 587-594 [DOI: 10.1007/s00270-008-9293-9]
12. Shimizu T, Sakuhara Y, Abo D, Hasegawa Y, Kodama Y, Endo H, Shirato H, Miyasaka K. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2009; 16: 816-823 [DOI: 10.1007/s00534-009-0124-4]
13. Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009; 58: 1-11 [DOI: 10.1016/j.cryobiol.2008.10.126]
14. Rovere-Querini P, Manfredi AA. Tumor destruction and in situ delivery of antigen presenting cells promote antineoplastic immune responses: implications for the immunotherapy of pancreatic cancer. JOP 2004; 5: 308-314
15. Palmer DH, Midgley RS, Mirza N, Torr EE, Ahmed F, Steele JC, Steven NM, Kerr DJ, Young LS, Adams DH. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology 2009; 49: 124-132 [DOI: 10.1002/hep.22626]
16. Lee WC, Wang HC, Hung CF, Huang PF, Lia CR, Chen MF. Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother 2005; 28: 496-504 [DOI: 10.1097/01.cji.0000171291.72039.e2]
17. Iwashita Y, Tahara K, Goto S, Sasaki A, Kai S, Seike M, Chen CL, Kawano K, Kitano S. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother 2003; 52: 155-161
18. Thanendrarajan S, Nowak M, Abken H, Schmidt-Wolf IG. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one? Leuk Res 2011; 35: 1136-1142 [DOI: 10.1016/j.leukres.2011.05.005]
19. Fazio MJ, Olsen DR, Uitto JJ. Skin aging: lessons from cutis laxa and elastoderma. Cutis 1989; 43: 437-444 [DOI: 10.3748/wjg.15.3664]
20. Azizi A, Naguib NN, Mbalisike E, Farshid P, Emami AH, Vogl TJ. Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas 2011; 40: 1271-1275 [DOI: 10.1097/MPA.0b013e318220e5b9]
21. Liaw YF, Lin DY. Transcatheter hepatic arterial embolization in the treatment of hepatocellular carcinoma. Hepatogastroenterology 1990; 37: 484-488
22. Li H, Wang C, Yu J, Cao S, Wei F, Zhang W, Han Y, Ren XB. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 2009; 11: 1076-1083 [DOI: 10.3109/14653240903121252]
23. Nakamura M, Wada J, Suzuki H, Tanaka M, Katano M, Morisaki T. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. Anticancer Res 2009; 29: 831-836
24. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2005; 16: 765-778 [DOI: 10.1097/01.RVI.0000170858.46668.65]
25. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247 [DOI: 10.1016/j.ejca.2008.10.026]
26. Pistorius GA, Alexander C, Krisch CM, Feifel G, Schilling MK, Menger MD. Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy. World J Surg 2005; 29: 657-660; discussion 661 [DOI: 10.1007/s00268-005-7543-4]
27. Plate J. Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Rev Vaccines 2011; 10: 825-836 [DOI: 10.1586/erv.11.77]
28. Walker AR, Walker BF, Vorster HH. Functional significance of mild-to-moderate malnutrition. Am J Clin Nutr 1990; 52: 178-179 [DOI: 10.1038/sj.bjc.6603341]
29. Schueller G, Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T, Jakesz R, Gnant M. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol 2003; 22: 1397-1402
30. Ali MY, Grimm CF, Ritter M, Mohr L, Allgaier HP, Weth R, Bocher WO, Endrulat K, Blum HE, Geissler M. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol 2005; 43: 817-822 [DOI: 10.1016/j.jhep.2005.04.016]
31. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4: 328-332 [DOI: 10.1038/nm0398-328]
32. Mackensen A, Herbst B, Chen JL, Köhler G, Noppen C, Herr W, Spagnoli GC, Cerundolo V, Lindemann A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer 2000; 86: 385-392
33. Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother 2006; 29: 545-557 [DOI: 10.1097/01.cji.0000211309.90621.8b]
34. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 1998; 16: 364-369 [DOI: 10.1038/nbt0498-364]
35. Zhu CZ, Norris JW. Seizures after stroke. Arch Neurol 1991; 48: 18-19 [DOI: 10.1016/S0264-410X(99) 00271-6]
36. Gilboa E, Vieweg J. Cancer immunotherapy with mRNAtransfected dendritic cells. Immunol Rev 2004; 199: 251-263 [DOI: 10.1111/j.0105-2896.2004.00139.x]
37. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 3: 558-561 [DOI: 10.1038/nm0597-558]
38. Akizuki S, Magara T, Tanaka T. [Diminution of the number of gamma delta T lymphocytes in hepatocellular carcinoma patients treated with transcatheter arterial embolization]. Nihon Rinsho Meneki Gakkai Kaishi 1998; 21: 108-117 [DOI: 10.2177/jsci.21.108]
39. Ayaru L, Pereira SP, Alisa A, Pathan AA, Williams R, Davidson B, Burroughs AK, Meyer T, Behboudi S. Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J Immunol 2007; 178: 1914-1922
40. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009; 252: 905-913 [DOI: 10.1148/radiol.2523081676]